EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Advances in Lipid‐Based Codelivery Systems for Cancer and Inflammatory Diseases

Chinmay M Jogdeo iD, Sudipta Panja iD, Shrey Kanvinde iD, Ekta Kapoor iD, Kasturi Siddhanta iD, David Oupický iD

Advanced Healthcare Materials · 2023-03 · 12 (7)

DOI: 10.1002/adhm.202202400 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 16.12.2022. Verfasst von Chinmay M Jogdeo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Drug Delivery and Nanomedicine, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, 68198, USA. Hauptthemen laut MEDLINE: Nanoparticles, Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, NIAAA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combination therapy targeting multiple therapeutic targets is a favorable strategy to achieve better therapeutic outcomes in cancer and inflammatory diseases. Codelivery is a subfield of drug delivery that aims to achieve combined delivery of diverse therapeutic cargoes within the same delivery system, thereby ensuring delivery to the same site and providing an opportunity to tailor the release kinetics as desired. Among the wide range of materials being investigated in the design of codelivery systems, lipids have stood out on account of their low toxicity, biocompatibility, and ease of formulation scale‐up. This review highlights the advances of the last decade in lipid‐based codelivery systems focusing on the codelivery of drug–drug, drug–nucleic acid, nucleic acid–nucleic acid, and protein therapeutic‐based combinations for targeted therapy in cancer and inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesNeoplasmsHumansDrug Delivery SystemsLipids

Stichwörter der Autor:innen

cancercodeliverycombination therapyinflammatory bowel diseaselipid nanoparticlespsoriasis

Substanzen

Lipids

Autor:innen und Institutionen

  • Center for Drug Delivery and Nanomedicine, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, 68198, USA.

ORCID-Profile: Chinmay M Jogdeo, Sudipta Panja, Shrey Kanvinde, Ekta Kapoor, Kasturi Siddhanta, David Oupický

Förderung

  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • NIAAA NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Jogdeo, C. M., Panja, S., Kanvinde, S., Kapoor, E., Siddhanta, K., & Oupický, D. (2023). Advances in Lipid‐Based Codelivery Systems for Cancer and Inflammatory Diseases. Advanced Healthcare Materials, 12(7). https://doi.org/10.1002/adhm.202202400

Vancouver

Jogdeo CM, Panja S, Kanvinde S, Kapoor E, Siddhanta K, Oupický D. Advances in Lipid‐Based Codelivery Systems for Cancer and Inflammatory Diseases. Advanced Healthcare Materials. 2023;12(7). doi:10.1002/adhm.202202400

BibTeX
@article{Jogdeo2023,
  author = {Jogdeo, Chinmay M and Panja, Sudipta and Kanvinde, Shrey and Kapoor, Ekta and Siddhanta, Kasturi and Oupický, David},
  title = {Advances in Lipid‐Based Codelivery Systems for Cancer and Inflammatory Diseases},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  volume = {12},
  number = {7},
  doi = {10.1002/adhm.202202400}
}
Kostenlos starten →